Recro Pharma DSO Ratio 2011-2026 | REPH

Annual DSO Ratio Recro Pharma

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
62.7	56.4	50.7	64.3	85.5	85.3	49.2	54.8	60.5	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
85.5	49.2	63.3

Quarterly DSO Ratio Recro Pharma

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
58.6	64.4	66.1	-	71.1	60.4	56	-	66.4	63.9	58.3	-	42.7	53.1	49.1	-	52	42	49.6	-	64.2	54	52.6	-	51.6	52.2	48.9	-	56	55	48.8	-	47.3	42	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
71.1	42	54.9

DSO Ratio of other stocks in the Drug manufacturers industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Aerie Pharmaceuticals AERI	117	-	-	$ 754 M	USA
Alimera Sciences ALIM	122	-	-	$ 142 M	USA
AcelRx Pharmaceuticals ACRX	16.5	-	7.5 %	$ 6.35 M	USA
Adamis Pharmaceuticals Corporation ADMP	71.7	-	0.86 %	$ 117 M	USA
Agile Therapeutics AGRX	63.1	-	10.11 %	$ 58.2 M	USA
Canopy Growth Corporation CGC	62.7	$ 1.1	2.84 %	$ 118 M	Canada
Cronos Group CRON	203	$ 2.64	1.35 %	$ 1.38 B	Canada
Catalent CTLT	80.1	-	-	$ 11.5 B	USA
Avadel Pharmaceuticals plc AVDL	49.9	-	-	$ 2.06 B	France
China Pharma Holdings CPHI	29.7	$ 0.59	6.08 %	$ 10.3 M	China
DURECT Corporation DRRX	100	-	-	$ 50.1 M	USA
Cumberland Pharmaceuticals CPIX	375	$ 3.81	-16.81 %	$ 53.6 M	USA
Eagle Pharmaceuticals EGRX	65.5	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	79.9	-	-	$ 28.9 M	Irlanda
Evolus EOLS	62.9	$ 5.68	37.53 %	$ 366 M	USA
HEXO Corp. HEXO	71.3	-	2.45 %	$ 38.1 M	Canada
Evoke Pharma EVOK	45.7	-	-	$ 36.6 M	USA
Harrow Health HROW	152	$ 40.02	3.65 %	$ 1.47 B	USA
Aurora Cannabis ACB	99.8	$ 3.65	4.89 %	$ 86.3 M	Canada
Athenex ATNX	89.9	-	-23.39 %	$ 1.76 M	USA
Jupiter Wellness JUPW	134	-	-	$ 33.6 M	USA
Emergent BioSolutions EBS	60.9	$ 8.95	0.39 %	$ 458 M	USA
Assertio Holdings ASRT	112	$ 12.19	2.48 %	$ 866 M	USA
Bausch Health Companies BHC	78.9	$ 5.67	-0.87 %	$ 2.07 B	Canada
Lannett Company LCI	83.1	-	1.15 %	$ 7.11 M	USA
Neoleukin Therapeutics NLTX	3.46	-	-	$ 193 M	Canada
OrganiGram Holdings OGI	93	$ 1.4	2.19 %	$ 402 M	Canada
Organogenesis Holdings ORGO	72.6	$ 2.87	0.01 %	$ 378 M	USA
Perrigo Company plc PRGO	53.9	$ 11.71	2.81 %	$ 1.62 B	USA
ProPhase Labs PRPH	111	-	-	$ 5.07 M	USA
Radius Health RDUS	16.1	-	-	$ 1.42 B	USA
Rockwell Medical RMTI	37.5	$ 0.91	1.03 %	$ 21.2 M	USA
Pacira BioSciences PCRX	50.3	$ 22.92	3.69 %	$ 1.06 B	USA
PetIQ PETQ	43.1	-	1.64 %	$ 400 M	USA
OptiNose OPTN	138	-	-	$ 1.08 B	USA
PLx Pharma PLXP	14.1	-	-27.8 %	$ 2.56 M	USA
SCYNEXIS SCYX	106	$ 0.76	1.22 %	$ 36.4 M	USA
Sonoma Pharmaceuticals SNOA	65.5	$ 2.74	-0.36 %	$ 3.4 M	USA
TherapeuticsMD TXMD	2.3 K	$ 2.25	1.35 %	$ 23.5 M	USA
Tilray TLRY	52.8	$ 7.33	-0.48 %	$ 4.53 B	Canada
Veru VERU	91.5	$ 2.53	0.4 %	$ 341 M	USA
Viatris VTRS	78.8	$ 14.74	-1.04 %	$ 17.7 B	USA
Zynerba Pharmaceuticals ZYNE	14.6 K	-	-	$ 55.5 M	USA
cbdMD YCBD	11.3	$ 0.75	-2.76 %	$ 3.23 M	USA